Somatic mutations and immunotherapy outcome with CTLA-4 blockade in melanoma

N Engl J Med. 2014 Dec 4;371(23):2230-2. doi: 10.1056/NEJMe1413061. Epub 2014 Nov 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • CTLA-4 Antigen / antagonists & inhibitors*
  • Female
  • Humans
  • Ipilimumab
  • Male
  • Melanoma / genetics*
  • Skin Neoplasms / genetics*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • CTLA-4 Antigen
  • Ipilimumab
  • tremelimumab